In this study, we investigated the role of β-arrestin-2 in alcohol preference using the two-bottle choice and conditioned place preference procedures in wild-type (WT) and β-arrestin-2 knockout (KO) mice. Locomotion and righting refl ex tests were performed to test alcohol sensitivity. The possible molecular signals regulated by β-arrestin-2 were analyzed by Western blot. We found that β-arrestin-2 KO mice showed a marked increase in voluntary alcohol consumption without significant differences in preference for saccharin or aversion to quinine. These animals also exhibited higher conditioned place preference scores for alcohol than WT mice. Meanwhile, KO mice showed reduced sensitivity to alcohol and increased blood alcohol clearance. Furthermore, after the free consumption of alcohol, the activities of protein kinase B and glycogen synthase kinase 3β (GSK3β) increased in the dorsal striatum of WT mice, but not in KO mice, which showed high basal activity of Akt in the dorsal striatum. These results suggest that β-arrestin-2 negatively regulates alcohol preference and reward, likely through regulating the activation of signaling pathways including Akt/GSK3β in the dorsal striatum.
INTRODUCTION
Alcohol addiction is a complex behavioral disorder characterized by repetitive and excessive alcohol drinking, which ultimately leads to a loss of control over consumption, the development of tolerance and dependence, and impairment of social and occupational functions [1] . Studies indicate that the development of alcohol addiction is a result of the interplay between genetics and social environment [2, 3] . Accumulating evidence has suggested that neuronal responses to alcohol involve several G proteincoupled receptor (GPCR)-mediated signaling pathways, inducing short-term to long-term changes in behavioral and neuronal plasticity [4] . Besides, alcohol increases dopamine release into the nucleus accumbens from projections that originate in the ventral tegmental area [5] , and dopamine D2 receptors in the nucleus accumbens regulate alcohol preference and intake [6] . Furthermore, an antagonist selective against dopamine D3 receptors decreases alcohol intake and prevents the relapse to alcohol-seeking behavior [7] . The G-protein βγ dimers regulate alcohol consumption through a synergy of D2 and adenosine A2
receptor-stimulated PKA signaling [8] . It was reported that agonists of the adenosine A2A receptor reduce alcohol consumption in alcohol-preferring rats [9] . Other GPCRs are also involved in alcohol dependence. Antagonists of CB1 cannabinoid and mGluR5 metabotropic receptors reduce alcohol intake in several animal models [10, 11] . These studies indicate that neurons in the limbic system orchestrate different GPCR signals during alcohol consumption;
however, the underlying mechanisms are not clear.
β-Arrestin-1 and β-arrestin-2 are important members of the arrestin family, and are ubiquitously expressed in the central nervous system in newborn and adult animals [12, 13] . Previous studies have shown that β-arrestins attenuate GPCR-mediated signal transduction and induce receptor internalization in an agonist-dependent manner [14] . β-Arrestins also interact with many signaling molecules and serve as scaffold proteins [15] . However their specific functions in the nervous system are not fully understood, though studies suggest that they are involved in the development of substance dependence.
Our earlier study showed that chronic morphine treatment and withdrawal regulate β-arrestin expression in the limbic system [16] . Bohn and colleagues reported that β-arrestin-2 knockout (KO) mice exhibit enhanced morphine analgesia, reduced tolerance to morphine, and enhanced morphineconditioned place preference [17] [18] [19] [20] . Recent studies showed that β-arrestins function as signaling molecules in the nervous system [21] . For example, β-arrestin-2 forms a signal complex with Akt to mediate dopamine-dependent behaviors [22] , interacts with ERK and affects its kinase activity, and is responsible for morphine-dependent D1
receptor activation and increased locomotion [23] . Moreover, Bjork et al. reported that β-arrestin-2 defi cient mice exhibit reduced voluntary consumption of a solution containing 6% alcohol and 0.2% saccharin [24] , suggesting that it plays a role in alcohol dependence. This study therefore aimed to investigate the role of β-arrestin-2 and the possible molecular signals in alcohol preference. 
MATERIALS AND METHODS

Animals
Two-Bottle Choice Model
To measure alcohol preference, a two-bottle free-choice procedure was performed in WT, β-arrestin-1 KO, and β-arrestin-2 KO mice. One bottle was fi lled with sterilized tap water and the other contained different concentrations of alcohol (3% to 15%, v/v) [25] . Animals were singlehoused and had continuous access to the contents of both bottles. They were exposed to ascending alcohol concentrations for 4-5 days. Alcohol and water intake
were measured daily at 13:00, and the bottle position was switched daily to avoid side preference. One month after this procedure, the saccharin (sweet) and quinine (bitter) intake and preference tests were performed in these mice as previously described [26] . Mice were sequentially given 
Locomotion Test
Plexiglas chambers (43 cm 2 ) were used for the locomotion test (Med-Associates, St. Albans, VT), and basal activity was recorded for 60 min once a day for three days. Basal activity was expressed as the distance traveled in the chamber (cm/h). On the fourth day, WT and β-arrestin-2 KO mice were given one injection of 20% alcohol (2.0 g/ kg, i.p.) immediately before the start of activity monitoring.
Horizontal traveled distance (cm) was recorded for 15 min after alcohol injection [27] .
Righting Refl ex Tests
Mice were given an injection of a high dose of 20% alcohol (4.0 g/kg, i.p.) and were intermittently placed on their backs.
The time (min) to regain the righting refl ex was measured as described previously [28] .
Alcohol-Induced Conditioned Place Preference (CPP)
Alcohol-induced CPP was measured in a two-chamber apparatus (each chamber was 27.3 × 27.3 cm 2 , Med
Associates) with different floor textures (rods or a grid) and a central partition with a manual door. The protocol for alcohol-induced CPP behavior was adopted from previous studies [29, 30] . Before the conditioning training phase, a habituation test was done on day 1. In this test, mice were placed in the CPP apparatus and allowed free access to the entire apparatus for 15 min. The time spent in each chamber was recorded to detect any initial bias. Mice that showed a basal preference >65% in either chamber were excluded from the study. Conditioning training consisted of two conditioning trials per day for three days (days 2-4).
On the morning of day 2, mice were given saline solution 
Data Analysis
Comparisons of genotype × alcohol concentration effects on behaviors between groups were performed using twoway ANOVA followed by the post hoc Tukey test. BAC data were analyzed by t-test at each time point. CPP
and Western blot data were evaluated using one-way or two-way ANOVA followed by the post hoc Tukey's test.
Comparisons between two groups were performed with the t-test. Data are presented as mean ± SEM. Statistical signifi cance was set at P <0.05.
RESULTS
β-Arrestin-2 Defi ciency Enhanced Alcohol Consumption
To test whether β-arrestin-2 is necessary for alcohol consumption and preference, the β-arrestin-2 KO mice underwent the two-bottle choice test for alcohol preference.
At lower alcohol concentrations (3% to 7%), both WT 
β-Arrestin-2 Deficiency Decreased the Response to Acute Alcohol Treatment
Numerous studies have demonstrated an inverse relationship between the motivation for alcohol consumption and alcohol sensitivity [25] . Therefore, the alcohol-induced locomotor activity and righting reflex tests were used to assess the alcohol sensitivity of the mice. Basal spontaneous activity Moreover, the time required for regaining the righting refl ex after an injection of alcohol (4.0 g/kg) was markedly decreased in β-arrestin2 KO mice compared with WT littermates (Fig. 4B) [t-test, P = 0.008].
β-Arrestin-2 Deficiency Increased Blood Alcohol
Clearance β-Arrestin-2 KO mice had a lower BAC than their WT littermates at 60 and 90 min after alcohol injection ( 
Alcohol Consumption
It has been shown that β-arrestin-2 forms a complex with Akt and protein phosphatase 2 (PP2A), and thus is involved in D2 receptor-mediated dopaminergic signaling through dephosphorylating Akt and in turn activating GSK3β [22] . We thus examined the effect of chronic alcohol consumption and ablation of β-arrestin-2 on the activity of Akt/GSK3β. After one month of voluntary consumption of 9% alcohol, the pAkt levels in the dorsal striatum of WT and β-arrestin-2 KO mice were determined by Western blotting.
The chronic intake of alcohol increased the pAkt level at Thr308 (pAkt 308) in WT mice (Fig. 6A) and KO mice that drank alcohol compared with those that drank water. The levels of pAkt and pGSK3β were also tested in the ventral striatum of WT and KO mice treated with alcohol, but no difference was detected (Fig. 6C, D) .
Moreover, no changes in the pERK and pCREB levels were detected in either the dorsal or ventral striatum of both genotypes after one month of alcohol consumption ( 
DISCUSSION
The present study provides in vivo evidence for the involvement of β-arrestin-2 in alcohol preference and reward by showing that its deletion enhanced alcohol consumption and alcohol-induced CPP scores in mice.
β-Arrestin-2 defi ciency led to decreased responses to acute alcohol treatment. Also, the activity of Akt and GSK3β increased in the dorsal striatum of WT, but not KO mice during chronic free consumption of alcohol.
Björk et al. reported that β-arrestin-2 KO mice display reduced voluntary consumption of a solution containing 6% alcohol and 0.2% saccharin by two-bottle choice with gradually increasing alcohol concentrations from 2% to 6% [24] . In our study, the consumption and preference for alcohol in the ascending concentrations (3, 5, 7, 9, 11, 13 and 15%) were investigated in the two-bottle choice paradigm. The voluntary alcohol consumption of KO mice was signifi cantly greater than that of WT mice, especially at 15%, when there was a robust jump of alcohol intake in the KO mice. No difference in consumption or preference was observed between these two genotypes at ≤7%
alcohol. The discrepancy between our study and that by Björk et al. may be due to the different designs of the twobottle choice test. Another factor may be the background of the KO mice used. The mice in our study were backcrossed to C57BL/6J for 10 generations. Moreover, in the study by Björk et al., differences between WT and KO mice were found at 6% alcohol, whereas in the present study differences were found at higher doses (from 9% to 15%), which are more likely to be pharmacologically important.
Besides, we showed that β-arrestin-2 defi ciency increased the CPP scores, which is consistent with our data on voluntary alcohol consumption in the two-bottle choice test. Furthermore, as an important mediator of the GPCR signal pathway, β-arrestin-2 negatively regulates morphine analgesia and promotes morphine tolerance in mice [17] [18] [19] [20] , so the increased intake of alcohol in KO mice seems unlikely to be due to an elevated tolerance to alcohol. However, a recent human study did not fi nd an association between genetic polymorphisms of β-arrestin-2 and alcohol dependence in a Caucasian population [31] . The association between β-arrestin-2 and alcoholism in other cohorts still needs to be confi rmed.
The increased alcohol preference and the decreased alcohol-induced locomotion in β-arrestin-2 KO mice complement previous reports that β-arrestin-2 deficiency increases morphine-induced CPP [20] and decreases acute morphine-stimulated locomotor activity [23] . This profi le is also consistent with abundant animal data showing an inverse relation between motivational consumption and sensitivity to alcohol, as well as human data of an inverse relation between alcoholism risk and alcohol sensitivity [32, 33] . In addition, in this study the lack of alcohol-evoked hyperlocomotion in KO mice could not be explained by a general impairment in spontaneous locomotor activity as demonstrated by Tukey's HSD post hoc analysis: no signifi cant differences between WT and KO mice were found in the basal level of locomotor activity on days 2 and 3 of the test. The previous study from Lefkowitz's group showed hypolocomotion in β-arrestin-2 KO mice. In this study, we also found that β-arrestin-2 KO mice had a decreasing tendency (but without statistical signifi cance) in locomotion on day 1 when they were introduced to a novel open fi eld. This may be due to the difference in the environment where the locomotion was tested and the number of animals used for each test.
Our study showed that the change in alcohol clearance rate occurred 60 to 90 min, but not 15 or 30 min, after the acute alcohol injection in KO mice. So the hypolocomotion in KO mice detected 15 min after acute alcohol treatment could not be the consequence of a higher blood-alcohol clearance rate. These data support the idea that β-arrestin-2
regulates alcohol-related behavioral plasticity.
Previous studies showed that alcohol addiction is a psychiatric disorder associated with dysregulation of signaling systems and protein expression at the cellular level [1] . In this study, elevated pAkt basal activity was detected in the dorsal striatum of β-arrestin-2 KO mice, consistent with other findings that these mice exhibit disruption of the interaction of between Akt and PP2A, dysregulation of Akt/GSK3β signaling in the striatum, as well as abnormality in dopamine-dependent behaviors and the pharmacological effect of lithium [22, 34] . In addition, the phosphorylation of Akt and GSK3β did not change in the ventral striatum of WT mice after chronic voluntary alcohol consumption. A recent study showed that Akt is activated in the nucleus accumbens in response to acute alcohol injection or withdrawal from excessive alcohol drinking [35] . Another study showed that acute alcohol injection stimulates Akt activation in the striatum, which is suppressed by opioid receptor antagonists but not D2
antagonists [36] . These results indicate that Akt is activated in specifi c brain areas at different stages of alcohol addiction.
In conclusion, the findings of this study support the hypothesis that β-arrestin-2 functions as a protective molecule to inhibit alcohol preference, likely through regulating the activation of signaling pathways including Akt/GSK3β in the dorsal striatum. β-Arrestin-2 may thus serve as a potential target of therapies for the treatment of alcoholism.
